Giessen Pulmonary Hypertension in Lung Cancer Registry — PHLHR

Pulmonary Hypertension Due to Lung Diseases and Hypoxia Clinical Trial

Official title:
Giessen Pulmonary Hypertension in Lung Cancer Registry

Status Recruiting

Clinical Trial Summary

The aim of this study is to investigate the frequency and implications of pulmonary hypertension in lung cancer patients. To do so, data will be collected from all lung cancer patients at the university hospital Giessen. All data will be analyzed for possible hints of pulmonary hypertension as a comorbidity in lung cancer patients. All information will be generated from the regular guidelines based course of treatment and there will be no interventions. This study will serve as a prospective register for all lung cancer patients treated at the university hospital Giessen.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Hypertension
Hypertension, Pulmonary
Hypoxia
Lung Diseases
Pulmonary Hypertension Due to Lung Diseases and Hypoxia

Clinical Trial Details

NCT number	NCT04467333
Study type	Observational [Patient Registry]
Source	University of Giessen
Contact	Bastian Eul, MD
Phone	(+49) 0641/985-42371
Email	bastian.eul@innere.med.uni-giessen.de
Status	Recruiting
Phase
Start date	June 29, 2020
Completion date	January 29, 2040

View Details

See also
	Status	Clinical Trial	Phase
	Recruiting	`NCT04499196` - Glucocorticoids and Pulmonary Hypertension
	Recruiting	`NCT04808596` - Pulmonary Hypertension Biorepository and Registry
	Not yet recruiting	`NCT06388421` - DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)